Converting 40% of Predicted Alerts Into Frontline Hodgkin's Lymphoma Treatments

Physicians who treated frontline Hodgkin's Lymphoma patients rarely saw more than a few cases each year, so predicting which promotional message would land, and when, was largely guesswork for the commercial team. A representative might visit a doctor's office weeks before or after that doctor's next patient needed a treatment decision, missing the window entirely. Physician access restrictions had narrowed the field's opportunities even further, leaving representatives with fewer chances to reach the right doctor at the right moment. Until then, the team had no reliable way to know which visits mattered most before the treatment decision had already been made, so timing decisions relied on general call cadence rather than any patient-specific signal.